FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anders Wallin

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Anatomy

Brain

Physiology

Co-author Network

Publications

TOP 3
Per Johansson; Niklas Mattsson; Anders Wallin; Henrik Zetterberg; Erik G Almqvist; Kaj Blennow; Oskar Hansson; Jan-Ove Johansson; Johan Svensson
Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer's disease.
Anna Poggesi; Giovanni Pracucci; Philip scheltens; Wiesje van der Flier; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; José M Ferro; Alida Gouw; Michael Hennerici; Domenico Inzitari; Peter Langhorne; John T O'Brien; Leonardo Pantoni
Cerebral white matter changes are associated with abnormalities on neurological examination in non-disabled elderly: the LADIS study.
Carla Moleiro; John O'Brien; Leonardo Pantoni; Anna Poggesi; Emilia Salvadori; Philip scheltens; Ana Verdelho; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; José M Ferro; Michael Hennerici; Domenico Inzitari; Sofia Madureira
Confirmatory factor analysis of the Neuropsychological Assessment Battery of the LADIS study: a longitudinal analysis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anders Wallin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Per Johansson; Niklas Mattsson; Anders Wallin; Henrik Zetterberg; Erik G Almqvist; Kaj Blennow; Oskar Hansson; Jan-Ove Johansson; Johan Svensson
Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer's disease.
Psychoneuroendocrinology 2013;38(7):1058-66.
2013: Anna Poggesi; Giovanni Pracucci; Philip scheltens; Wiesje van der Flier; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; José M Ferro; Alida Gouw; Michael Hennerici; Domenico Inzitari; Peter Langhorne; John T O'Brien; Leonardo Pantoni
Cerebral white matter changes are associated with abnormalities on neurological examination in non-disabled elderly: the LADIS study.
Journal of neurology 2013;260(4):1014-21.
2013: Carla Moleiro; John O'Brien; Leonardo Pantoni; Anna Poggesi; Emilia Salvadori; Philip scheltens; Ana Verdelho; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; José M Ferro; Michael Hennerici; Domenico Inzitari; Sofia Madureira
Confirmatory factor analysis of the Neuropsychological Assessment Battery of the LADIS study: a longitudinal analysis.
Journal of clinical and experimental neuropsychology 2013;35(3):269-78.
2013: Marie Eckerström; Mattias Göthlin; Boo Johansson; Sindre Rolstad; Johanna Skoogh; Gunnar Steineck; Anders Wallin
Sahlgrenska Academy Self-reported Cognitive Impairment Questionnaire (SASCI-Q) - a research tool discriminating between subjectively cognitively impaired patients and healthy controls.
International psychogeriatrics / IPA 2013;25(3):420-30.
2013: Erik Olsson; Josef Berge; Carl Eckerström; Ake Edman; Niklas Klasson; Helge Malmgren; Anders Wallin
White Matter Lesion Assessment in Patients with Cognitive Impairment and Healthy Controls: Reliability Comparisons between Visual Rating, a Manual, and an Automatic Volumetrical MRI Method-The Gothenburg MCI Study.
Journal of aging research 2013;2013():198471.
2013: Anne Ingeborg Berg; Arto Nordlund; Anders Wallin; Boo Johansson
Living with stable MCI: experiences among 17 individuals evaluated at a memory clinic.
Aging & mental health 2013;17(3):293-9.
2013: Sindre Rolstad; Anne Ingeborg Berg; Maria Bjerke; Boo Johansson; Henrik Zetterberg; Anders Wallin
Cerebrospinal fluid biomarkers mirror rate of cognitive decline.
Journal of Alzheimer's disease : JAD 2013;34(4):949-56.
2012: Ana Verdelho; Gunhild Waldemar; Anders Wallin; Hansjoerg Baezner; Christian Blahak; Timo Erkinjuntti; Franz Fazekas; José M Ferro; Michael Hennerici; Domenico Inzitari; Sofia Madureira; Leonardo Pantoni; Anna Poggesi; Philip scheltens
Physical activity prevents progression for cognitive impairment and vascular dementia: results from the LADIS (Leukoaraiosis and Disability) study.
Stroke; a journal of cerebral circulation 2012;43(12):3331-5.
2012: Anders Wallin; Annika Ohrfelt; Maria Bjerke
Characteristic clinical presentation and CSF biomarker pattern in cerebral small vessel disease.
Journal of the neurological sciences 2012;322(1-2):192-6.
2012: Reinhold Schmidt; Wiesje M van der Flier; Ana Verdelho; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Frederik Barkhof; Andrea Berghold; Timo Erkinjuntti; Franz Fazekas; José M Ferro; Alida A Gouw; Domenico Inzitari; Hanna Jokinen; Sofia Madureira; Leonardo Pantoni; Katja Petrovic; Anna Poggesi; Philip scheltens
White matter lesion progression in LADIS: frequency, clinical effects, and sample size calculations.
Stroke; a journal of cerebral circulation 2012;43(10):2643-7.
2012: Michael J Firbank; Alida A Gouw; Domenico Inzitari; Peter Langhorne; John T O'Brien; Leonardo Pantoni; Anna Poggesi; Giovanni Pracucci; Andrew Teodorczuk; Wiesje M van der Flier; Lars-Olof Wahlund; Anders Wallin; Timo Erkinjuntti
Relationship between progression of brain white matter changes and late-life depression: 3-year results from the LADIS study.
The British journal of psychiatry : the journal of mental science 2012;201(1):40-5.
2012: Sara Landgren; Jan Marcusson; Lennart Minthon; Staffan Nilsson; Mona Seibt Palmér; Ingmar Skoog; Malin von Otter; Anders Wallin; Henrik Zetterberg; Caroline Zetterström; Niels Andreasen; Kaj Blennow; Nenad Bogdanovic; Deborah R Gustafson; Petronella Kettunen
A novel ARC gene polymorphism is associated with reduced risk of Alzheimer's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2012;119(7):833-42.
2012: Marcin Kruczyk; Lennart Minthon; Sindre Rolstad; Anders Wallin; Henrik Zetterberg; Kaj Blennow; Oskar Hansson; Jan Komorowski; Mats Gunnar Andersson
Monte Carlo feature selection and rule-based models to predict Alzheimer's disease in mild cognitive impairment.
Journal of neural transmission (Vienna, Austria : 1996) 2012;119(7):821-31.
2012: Hanna Jokinen; J Lipsanen; Sofia Madureira; Leonardo Pantoni; Reinhold Schmidt; Wiesje M van der Flier; Ana Verdelho; Anders Wallin; Frederik Barkhof; Timo Erkinjuntti; Franz Fazekas; José M Ferro; Alida A Gouw; Domenico Inzitari
Brain atrophy accelerates cognitive decline in cerebral small vessel disease: the LADIS study.
Neurology 2012;78(22):1785-92.
2012: Sofia Movérare-Skrtic; Anders Wallin; Henrik Zetterberg; Kaj Blennow; Oskar Hansson; Jan-Ove Johansson; Per Johansson; Niklas Mattsson; Johan Svensson
Leukocyte telomere length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's disease: a pilot study.
Experimental gerontology 2012;47(2):179-82.
2012: Johanna Skoogh; Gunnar Steineck; Ulrika Stierner; Anders Wallin; Ulrica Wilderäng; Eva Cavallin-Ståhl; Margaret Gatz; Boo Johansson
Testicular-cancer survivors experience compromised language following chemotherapy: findings in a Swedish population-based study 3-26 years after treatment.
Acta oncologica (Stockholm, Sweden) 2012;51(2):185-97.
2012: Michael Jonsson; Karin Lind; Leonardo Pantoni; Sindre Rolstad; Maria Bjerke; Kaj Blennow; Ake Edman; Alida A Gouw; Domenico Inzitari; Henrik Zetterberg; Anders Wallin
Low cerebrospinal fluid sulfatide predicts progression of white matter lesions: The LADIS study.
Dementia and geriatric cognitive disorders 2012;34(1):61-7.
2012: Niklas Mattsson; Erik Portelius; Sindre Rolstad; Mats Stridsberg; Anders Wallin; Ulf Andreasson; Kaj Blennow; Mikael Gustavsson; Henrik Zetterberg
Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment.
Journal of Alzheimer's disease : JAD 2012;30(4):767-78.
2011: Annika Ohrfelt; Rita Persson; Dzemila Secic; Eugeen Vanmechelen; Anders Wallin; Dag Aarsland; Kerstin Andersson; Clive G Ballard; Kaj Blennow; Gunnar Brinkmalm; Paul T Francis; Ezra Mulugeta; Henrik Zetterberg; Ann Westman-Brinkmalm
Identification of novel α-synuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS method.
Neurochemical research 2011;36(11):2029-42.
2011: Per Johansson; Fernand Labrie; Niklas Mattsson; Claes Ohlsson; Kaj Blennow; Oskar Hansson; Jan-Ove Johansson; Anders Wallin; Henrik Zetterberg; Johan Svensson
Mild dementia is associated with increased adrenal secretion of cortisol and precursor sex steroids in women.
Clinical endocrinology 2011;75(3):301-8.
2011: Arto Nordlund; Lisbeth Påhlsson; Christina Holmberg; Karin Lind; Anders Wallin
The Cognitive Assessment Battery (CAB): a rapid test of cognitive domains.
International psychogeriatrics / IPA 2011;23(7):1144-51.
2011: Niklas Mattsson; Shahrzad Tabatabaei; Per Johansson; Oskar Hansson; Ulf Andreasson; Jan-Eric Månsson; Jan-Ove Johansson; Bob Olsson; Anders Wallin; Johan Svensson; Kaj Blennow; Henrik Zetterberg
Cerebrospinal fluid microglial markers in Alzheimer's disease: elevated chitotriosidase activity but lack of diagnostic utility.
Neuromolecular medicine 2011;13(2):151-9.
2011: Thiemo Rudolph; Annica Sjölander; Mona Seibt Palmér; Lennart Minthon; Anders Wallin; Niels Andreasen; Gunnar Tasa; Erkki Juronen; Kaj Blennow; Henrik Zetterberg; Madeleine Zetterberg
Ubiquitin carboxyl-terminal esterase L1 (UCHL1) S18Y polymorphism in patients with cataracts.
Ophthalmic genetics 2011;32(2):75-9.
2011: Kaj Blennow; M Jonsson; Niels Andreasen; Lars Rosengren; Anders Wallin; P A Hellström; Henrik Zetterberg
No neurochemical evidence of brain injury after blast overpressure by repeated explosions or firing heavy weapons.
Acta neurologica Scandinavica 2011;123(4):245-51.
2011: Arto Nordlund; Mattias Göthlin; Anders Wallin
Vascular disease, Alzheimer's disease biomarkers and cognition in mild cognitive impairment: additive or synergetic effects?
Dementia and geriatric cognitive disorders 2011;32(4):250-6.
2011: Ana Verdelho; Gunhild Waldemar; Anders Wallin; Timo Erkinjuntti; Franz Fazekas; José M Ferro; Domenico Inzitari; Sofia Madureira; Carla Moleiro; Leonardo Pantoni; Anna Poggesi; Catarina O Santos; Philip scheltens
Self-perceived memory complaints predict progression to Alzheimer disease. The LADIS study.
Journal of Alzheimer's disease : JAD 2011;27(3):491-8.
2011: Sindre Rolstad; Henrik Zetterberg; Anne Ingeborg Berg; Maria Bjerke; Kaj Blennow; Boo Johansson; Anders Wallin
Amyloid-β₄₂ is associated with cognitive impairment in healthy elderly and subjective cognitive impairment.
Journal of Alzheimer's disease : JAD 2011;26(1):135-42.
2011: Christoffer Rosén; Niklas Mattsson; Per M Johansson; Ulf Andreasson; Anders Wallin; Oskar Hansson; Jan-Ove Johansson; John Lamont; Johan Svensson; Kaj Blennow; Henrik Zetterberg
Discriminatory Analysis of Biochip-Derived Protein Patterns in CSF and Plasma in Neurodegenerative Diseases.
Frontiers in aging neuroscience 2011;3():1.
2011: Per Johansson; Niklas Mattsson; Anders Wallin; Henrik Zetterberg; Ulf Andreasson; Kaj Blennow; Oskar Hansson; Jan-Ove Johansson; Johan Svensson
Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population.
Journal of Alzheimer's disease : JAD 2011;24(3):537-46.
2011: C Eckerström; E Olsson; N Klasson; M Bjerke; M Göthlin; Michael Jonsson; Sindre Rolstad; H Malmgren; Anders Wallin; Ake Edman
High white matter lesion load is associated with hippocampal atrophy in mild cognitive impairment.
Dementia and geriatric cognitive disorders 2011;31(2):132-8.
2010: Malin von Otter; Sara Landgren; Staffan Nilsson; Caroline Lundvall; Lennart Minthon; Nenad Bogdanovic; Niels Andreasen; Deborah R Gustafson; Ingmar Skoog; Anders Wallin; Anna Zettergren; Hans Nissbrandt; Madeleine Zetterberg; Gunnar Tasa; Kaj Blennow; Henrik Zetterberg
Kinesin light chain 1 gene haplotypes in three conformational diseases.
Neuromolecular medicine 2010;12(3):229-36.
2010: Sara Landgren; Mona Seibt Palmér; Ingmar Skoog; Lennart Minthon; Anders Wallin; Niels Andreasen; Madeleine Zetterberg; Kaj Blennow; Henrik Zetterberg
No association of VEGF polymorphims with Alzheimer's disease.
Neuromolecular medicine 2010;12(3):224-8.
2010: Ana Verdelho; S Madureira; C Moleiro; José M Ferro; C O Santos; Timo Erkinjuntti; Leonardo Pantoni; Franz Fazekas; M Visser; Gunhild Waldemar; Anders Wallin; Michael Hennerici; Domenico Inzitari
White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study.
Neurology 2010;75(2):160-7.
2010: Valgeir Thorvaldsson; Arto Nordlund; Ivar Reinvang; Kaj Blennow; Henrik Zetterberg; Anders Wallin; Boo Johansson
Memory in individuals with mild cognitive impairment in relation to APOE and CSF Abeta42.
International psychogeriatrics / IPA 2010;22(4):598-606.
2010: R Astrand; S Rolstad; Anders Wallin
Cognitive Impairment Questionnaire (CIMP-QUEST): reported topographic symptoms in MCI and dementia.
Acta neurologica Scandinavica 2010;121(6):384-91.
2010: M Jonsson; A Edman; K Lind; S Rolstad; M Sjögren; Anders Wallin
Apathy is a prominent neuropsychiatric feature of radiological white-matter changes in patients with dementia.
International journal of geriatric psychiatry 2010;25(6):588-95.
2010: Anders Wallin; Kaj Blennow; Henrik Zetterberg; Elisabet Londos; Lennart Minthon; Oskar Hansson
CSF biomarkers predict a more malignant outcome in Alzheimer disease.
Neurology 2010;74(19):1531-7.
2010: Damien L Bruno; Britt-Marie Anderlid; Anna Lindstrand; Conny van Ravenswaaij-Arts; Devika Ganesamoorthy; Johanna Lundin; Christa Lese Martin; Jessica Douglas; Catherine Nowak; Margaret P Adam; R Frank Kooy; Nathalie Van der Aa; Edwin Reyniers; Geert Vandeweyer; Irene Stolte-Dijkstra; Trijnie Dijkhuizen; Alison Yeung; Martin B Delatycki; Birgit Borgström; Lena Thelin; Carlos Cardoso; Bregje van Bon; Rolph Pfundt; Bert B A de Vries; Anders Wallin; David J Amor; Paul A James; Howard R Slater; Jacqueline Schoumans
Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypes.
Journal of medical genetics 2010;47(5):299-311.
2010: Reinhold Schmidt; Stefan Ropele; José Ferro; Sofia Madureira; Ana Verdelho; Katja Petrovic; Alida A Gouw; Wiesje M van der Flier; Christian Enzinger; Leonardo Pantoni; Domenico Inzitari; Timo Erkinjuntti; Philip scheltens; Lars-Olof Wahlund; Gunhild Waldemar; Egill Rostrup; Anders Wallin; Frederik Barkhof; Franz Fazekas
Diffusion-weighted imaging and cognition in the leukoariosis and disability in the elderly study.
Stroke; a journal of cerebral circulation 2010;41(5):e402-8.
2010: Arto Nordlund; Sindre Rolstad; Ola Klang; Ake Edman; Stefan Hansen; Anders Wallin
Two-year outcome of MCI subtypes and aetiologies in the Göteborg MCI study.
Journal of neurology, neurosurgery, and psychiatry 2010;81(5):541-6.
2010: Andrew Teodorczuk; Michael J Firbank; L Pantoni; A Poggesi; T Erkinjuntti; Anders Wallin; Lars-Olof Wahlund; Philip scheltens; G Waldemar; G Schrotter; J M Ferro; H Chabriat; H Bazner; M Visser; D Inzitari; John T O'Brien
Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study.
Psychological medicine 2010;40(4):603-10.
2010: K Schultz; K Nilsson; J E Nielsen; S G Lindquist; L E Hjermind; B B Andersen; Anders Wallin; C Nilsson; Asa Petersén
Transthyretin as a potential CSF biomarker for Alzheimer's disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2010;17(3):456-60.
2010: Michael Jonsson; Henrik Zetterberg; E van Straaten; Karin Lind; Steinar Syversen; Ake Edman; Kaj Blennow; Lars Rosengren; Leonardo Pantoni; D Inzitari; Anders Wallin
Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2010;17(3):377-82.
2010: Oskar Hansson; Henrik Zetterberg; Eugeen Vanmechelen; hugo vanderstichele; Ulf Andreasson; Elisabet Londos; Anders Wallin; Lennart Minthon; Kaj Blennow
Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.
Neurobiology of aging 2010;31(3):357-67.
2010: Malin von Otter; Sara Landgren; Staffan Nilsson; Madeleine Zetterberg; Dragana Celojevic; Petra Bergström; Lennart Minthon; Nenad Bogdanovic; Niels Andreasen; Deborah R Gustafson; Ingmar Skoog; Anders Wallin; Gunnar Tasa; Kaj Blennow; Michael Nilsson; Ola Hammarsten; Henrik Zetterberg
Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract.
Mechanisms of ageing and development 2010;131(2):105-10.
2010: Arto Nordlund; Sindre Rolstad; Mattias Göthlin; Ake Edman; Stefan Hansen; Anders Wallin
Cognitive profiles of incipient dementia in the Goteborg MCI study.
Dementia and geriatric cognitive disorders 2010;30(5):403-10.
2010: Maria Bjerke; Erik Portelius; Lennart Minthon; Anders Wallin; Henrik Anckarsäter; Rolf Anckarsäter; Niels Andreasen; Henrik Zetterberg; Ulf Andreasson; Kaj Blennow
Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid.
International journal of Alzheimer's disease 2010;2010():.
2010: Patrick Quinlan; Arto Nordlund; Karin Lind; Deborah Gustafson; Ake Edman; Anders Wallin
Thyroid hormones are associated with poorer cognition in mild cognitive impairment.
Dementia and geriatric cognitive disorders 2010;30(3):205-11.
2010: Anders Wallin; Tormod Fladby
Do white matter hyperintensities on MRI matter clinically?
BMJ (Clinical research ed.) 2010;341():c3400.
2010: Sindre Rolstad; Arto Nordlund; Carl Eckerström; Marie H Gustavsson; Kaj Blennow; Pernille J Olesen; Henrik Zetterberg; Anders Wallin
High education may offer protection against tauopathy in patients with mild cognitive impairment.
Journal of Alzheimer's disease : JAD 2010;21(1):221-8.
2010: Niklas Mattsson; Per Johansson; Oskar Hansson; Anders Wallin; Jan-Ove Johansson; Ulf Andreasson; Oluf Andersen; Sara Haghighi; Maria Olsson; Mats Stridsberg; Johan Svensson; Kaj Blennow; Henrik Zetterberg
Converging pathways of chromogranin and amyloid metabolism in the brain.
Journal of Alzheimer's disease : JAD 2010;20(4):1039-49.
2010: Sofia Madureira; Ana Verdelho; Carla Moleiro; José M Ferro; Timo Erkinjuntti; Hanna Jokinen; Leonardo Pantoni; Franz Fazekas; Wiesje M van der Flier; Marieke Visser; Gunhild Waldemar; Anders Wallin; Michael Hennerici; Domenico Inzitari
Neuropsychological predictors of dementia in a three-year follow-up period: data from the LADIS study.
Dementia and geriatric cognitive disorders 2010;29(4):325-34.
2010: C Eckerström; U Andreasson; E Olsson; S Rolstad; Kaj Blennow; Henrik Zetterberg; H Malmgren; A Edman; Anders Wallin
Combination of hippocampal volume and cerebrospinal fluid biomarkers improves predictive value in mild cognitive impairment.
Dementia and geriatric cognitive disorders 2010;29(4):294-300.
2010: Madeleine Zetterberg; Annica Sjölander; Malin von Otter; Mona Seibt Palmér; Sara Landgren; Lennart Minthon; Anders Wallin; Niels Andreasen; Kaj Blennow; Henrik Zetterberg
Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y polymorphism in Alzheimer's disease.
Molecular neurodegeneration 2010;5():11.
2009: Niklas Mattsson; Henrik Zetterberg; Oskar Hansson; Niels Andreasen; Lucilla Parnetti; Michael Jonsson; Sanna-Kaisa Herukka; Wiesje M van der Flier; Marinus A Blankenstein; Michael Ewers; Kenneth Rich; Elmar Kaiser; Marcel Verbeek; Magda Tsolaki; Ezra Mulugeta; Erik Rosén; Dag Aarsland; Pieter Jelle Visser; Johannes Schröder; Jan Marcusson; Mony de Leon; Harald Hampel; Philip scheltens; Tuula Pirttilä; Anders Wallin; Maria Eriksdotter Jönhagen; Lennart Minthon; Bengt Winblad; Kaj Blennow
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.
JAMA : the journal of the American Medical Association 2009;302(4):385-93.
2009: Daniel Kondziella; Mattias Göthlin; Michael Fu; Henrik Zetterberg; Anders Wallin
B-type natriuretic peptide plasma levels are elevated in subcortical vascular dementia.
Neuroreport 2009;20(9):825-7.
2009: Christian Blahak; Hansjoerg Baezner; Leonardo Pantoni; A Poggesi; H Chabriat; Timo Erkinjuntti; Franz Fazekas; José M Ferro; P Langhorne; John T O'Brien; M C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Domenico Inzitari; Michael G Hennerici
Deep frontal and periventricular age related white matter changes but not basal ganglia and infratentorial hyperintensities are associated with falls: cross sectional results from the LADIS study.
Journal of neurology, neurosurgery, and psychiatry 2009;80(6):608-13.
2009: Anders Wallin; Oskar Hansson; Kaj Blennow; Elisabet Londos; Lennart Minthon
Can CSF biomarkers or pre-treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease?
International journal of geriatric psychiatry 2009;24(6):638-47.
2009: Anders Wallin
[Vascular cognitive impairment a spectrum of diseases].
Läkartidningen 2009;106(20):1377-80.
2009: Miroslaw Brys; Elizabeth Pirraglia; Kenneth Rich; Sindre Rolstad; Lisa Mosconi; Remigiusz Switalski; Lidia Glodzik-Sobanska; Susan De Santi; Raymond Zinkowski; Pankaj Mehta; Domenico Pratico'; LA Saint Louis; Anders Wallin; Kaj Blennow; Mony J de Leon
Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment.
Neurobiology of aging 2009;30(5):682-90.
2009: Kristofer Schultz; Sara Wiehager; Karin Nilsson; Jørgen E Nielsen; Suzanne G Lindquist; Lena E Hjermind; Birgitte B Andersen; Anders Wallin; Christer Nilsson; Asa Petersén
Reduced CSF CART in dementia with Lewy bodies.
Neuroscience letters 2009;453(2):104-6.
2009: Niklas Mattsson; M Axelsson; S Haghighi; C Malmeström; G Wu; R Anckarsäter; S Sankaranarayanan; U Andreasson; Sten Fredrikson; A Gundersen; L Johnsen; T Fladby; A Tarkowski; E Trysberg; Anders Wallin; H Anckarsäter; J Lycke; Oluf Andersen; A J Simon; Kaj Blennow; Henrik Zetterberg
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2009;15(4):448-54.
2009: Annica Sjölander; Lennart Minthon; Nenad Bogdanovic; Anders Wallin; Henrik Zetterberg; Kaj Blennow
The PPAR-alpha gene in Alzheimer's disease: lack of replication of earlier association.
Neurobiology of aging 2009;30(4):666-8.
2009: Kaj Blennow; Geert De Meyer; Oskar Hansson; L Minthon; Anders Wallin; Henrik Zetterberg; P Lewczuk; hugo vanderstichele; E Vanmechelen; J Kornhuber; J Wiltfang; I Heuser; W Maier; C Luckhaus; E Rüther; M Hüll; H Jahn; H J Gertz; Lutz Froelich; Harald Hampel; R Pernetzki
Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment.
The journal of nutrition, health & aging 2009;13(3):205-8.
2009: Lennart Minthon; Anders Wallin; S Eriksson; C Wattmo; Niels Andreasen
Long-term rivastigmine treatment in a routine clinical setting.
Acta neurologica Scandinavica 2009;119(3):180-5.
2009: Annika Ohrfelt; Pierre Grognet; Niels Andreasen; Anders Wallin; Eugeen Vanmechelen; Kaj Blennow; Henrik Zetterberg
Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
Neuroscience letters 2009;450(3):332-5.
2009: Stefan Ropele; Alexandra Seewann; Alida A Gouw; Wiesje M van der Flier; Reinhold Schmidt; Leonardo Pantoni; Domenico Inzitari; Timo Erkinjuntti; Philip scheltens; Lars-Olof Wahlund; Gunhild Waldemar; Hugues Chabriat; José Ferro; Michael Hennerici; John T O'Brien; Anders Wallin; Peter Langhorne; Marieke C Visser; Frederik Barkhof; Franz Fazekas
Quantitation of brain tissue changes associated with white matter hyperintensities by diffusion-weighted and magnetization transfer imaging: the LADIS (Leukoaraiosis and Disability in the Elderly) study.
Journal of magnetic resonance imaging : JMRI 2009;29(2):268-74.
2009: Maria Bjerke; Ulf Andreasson; Sindre Rolstad; Arto Nordlund; Karin Lind; Henrik Zetterberg; Ake Edman; Kaj Blennow; Anders Wallin
Subcortical vascular dementia biomarker pattern in mild cognitive impairment.
Dementia and geriatric cognitive disorders 2009;28(4):348-56.
2009: Sindre Rolstad; Arto Nordlund; C Eckerström; M H Gustavsson; Henrik Zetterberg; Anders Wallin
Cognitive reserve in relation to abeta42 in patients converting from MCI to dementia - a follow-up report.
Dementia and geriatric cognitive disorders 2009;28(2):110-5.
2009: Domenico Inzitari; Giovanni Pracucci; Anna Poggesi; Giovanna Carlucci; Frederik Barkhof; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; José M Ferro; Michael Hennerici; Peter Langhorne; John T O'Brien; Philip scheltens; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Leonardo Pantoni
Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort.
BMJ (Clinical research ed.) 2009;339():b2477.
2009: Hanna Jokinen; Hely Kalska; Raija Ylikoski; Sofia Madureira; Ana Verdelho; Wiesje M van der Flier; Philip scheltens; Frederik Barkhof; Marieke C Visser; Franz Fazekas; Reinhold Schmidt; John T O'Brien; Gunhild Waldemar; Anders Wallin; Hugues Chabriat; Leonardo Pantoni; Domenico Inzitari; Timo Erkinjuntti
Longitudinal cognitive decline in subcortical ischemic vascular disease--the LADIS Study.
Cerebrovascular diseases (Basel, Switzerland) 2009;27(4):384-91.
2009: Sindre Rolstad; Arto Nordlund; C Eckerström; M H Gustavsson; Henrik Zetterberg; Anders Wallin
Biomarkers in relation to cognitive reserve in patients with mild cognitive impairment--proof of concept.
Dementia and geriatric cognitive disorders 2009;27(2):194-200.
2009: Sara F Hansson; Ulf Andréasson; Mariann Wall; Ingmar Skoog; Niels Andreasen; Anders Wallin; Henrik Zetterberg; Kaj Blennow
Reduced levels of amyloid-beta-binding proteins in cerebrospinal fluid from Alzheimer's disease patients.
Journal of Alzheimer's disease : JAD 2009;16(2):389-97.
2009: Miroslaw Brys; Lidia Glodzik; Lisa Mosconi; Remigiusz Switalski; Susan De Santi; Elizabeth Pirraglia; Kenneth Rich; Byeong C Kim; Pankaj Mehta; Raymond Zinkowski; Domenico Pratico'; Anders Wallin; Henrik Zetterberg; Wai Hon Tsui; Henry Rusinek; Kaj Blennow; Mony J de Leon
Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2009;16(2):351-62.
2009: Hanna Jokinen; Hely Kalska; Raija Ylikoski; Sofia Madureira; Ana Verdelho; Alida Gouw; Philip scheltens; Frederik Barkhof; Marieke C Visser; Franz Fazekas; Reinhold Schmidt; John T O'Brien; Michael Hennerici; Hansjorg Baezner; Gunhild Waldemar; Anders Wallin; Hugues Chabriat; Leonardo Pantoni; Domenico Inzitari; Timo Erkinjuntti
MRI-defined subcortical ischemic vascular disease: baseline clinical and neuropsychological findings. The LADIS Study.
Cerebrovascular diseases (Basel, Switzerland) 2009;27(4):336-44.
2008: Sindre Rolstad; Arto Nordlund; Marie Helene Gustavsson; Carl Eckerström; Ola Klang; Stefan Hansen; Anders Wallin
The Swedish National Adult Reading Test (NART-SWE): a test of premorbid IQ.
Scandinavian journal of psychology 2008;49(6):577-82.
2008: C Eckerström; E Olsson; M Borga; S Ekholm; S Ribbelin; Sindre Rolstad; Göran Starck; Ake Edman; Anders Wallin; H Malmgren
Small baseline volume of left hippocampus is associated with subsequent conversion of MCI into dementia: the Göteborg MCI study.
Journal of the neurological sciences 2008;272(1-2):48-59.
2008: Madeleine Zetterberg; Sara Landgren; Malin E Andersson; Mona Seibt Palmér; Deborah R Gustafson; Ingmar Skoog; Lennart Minthon; Dag Steinar Thelle; Anders Wallin; Nenad Bogdanovic; Niels Andreasen; Kaj Blennow; Henrik Zetterberg
Association of complement factor H Y402H gene polymorphism with Alzheimer's disease.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2008;147B(6):720-6.
2008: Anna Poggesi; Giovanni Pracucci; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; Ana Verdelho; Michael Hennerici; Peter Langhorne; John T O'Brien; Philip scheltens; Marieke C Visser; Milita Crisby; Gunhild Waldemar; Anders Wallin; Domenico Inzitari; Leonardo Pantoni
Urinary complaints in nondisabled elderly people with age-related white matter changes: the Leukoaraiosis And DISability (LADIS) Study.
Journal of the American Geriatrics Society 2008;56(9):1638-43.
2008: Bruno Miranda; Sofia Madureira; Ana Verdelho; Jose Ferro; Leonardo Pantoni; Emilia Salvadori; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; Michael Hennerici; John T O'Brien; Philip scheltens; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; D Inzitarion
Self-perceived memory impairment and cognitive performance in an elderly independent population with age-related white matter changes.
Journal of neurology, neurosurgery, and psychiatry 2008;79(8):869-73.
2008: Arto Nordlund; Sindre Rolstad; Ola Klang; Karin Lind; Mona Pedersen; Kaj Blennow; Ake Edman; Stefan Hansen; Anders Wallin
Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI.
Journal of the International Neuropsychological Society : JINS 2008;14(4):582-90.
2008: A H Simonsen; James McGuire; Vladimir N Podust; H Davies; Lennart Minthon; Ingmar Skoog; Niels Andreasen; Anders Wallin; Gunhild Waldemar; Kaj Blennow
Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease.
Neurobiology of aging 2008;29(7):961-8.
2008: Anders Wallin; Sture Eriksson; Lena Kilander; Lars-Olof Wahlund; Ragnar Astrand; Christer Nilsson
[Cognitive medicine--field of knowledge for future specialist education].
Läkartidningen 2008;105(26-27):1956-7.
2008: Michael Ewers; Zhenyu Zhong; Katharina Bürger; Anders Wallin; Kaj Blennow; Stefan J Teipel; Yong Shen; Harald Hampel
Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.
Brain : a journal of neurology 2008;131(Pt 5):1252-8.
2008: Igor Klyubin; Vicki Betts; Alfred T Welzel; Kaj Blennow; Henrik Zetterberg; Anders Wallin; Cynthia A Lemere; William K Cullen; Ying Peng; Thomas Wisniewski; Dennis J Selkoe; Roger Anwyl; Dominic M Walsh; Michael J Rowan
Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2008;28(16):4231-7.
2008: Hansjoerg Baezner; Christian Blahak; A Poggesi; Leonardo Pantoni; Domenico Inzitari; H Chabriat; Timo Erkinjuntti; Franz Fazekas; José M Ferro; P Langhorne; John T O'Brien; Philip scheltens; M C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Michael G Hennerici
Association of gait and balance disorders with age-related white matter changes: the LADIS study.
Neurology 2008;70(12):935-42.
2008: Carina Wattmo; Oskar Hansson; Anders Wallin; Elisabet Londos; Lennart Minthon
Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting.
Dementia and geriatric cognitive disorders 2008;26(3):203-11.
2007: Michael Ewers; Katharina Buerger; Stefan J Teipel; Philip scheltens; J Schröder; Raymond Zinkowski; Femke H Bouwman; Peter Schönknecht; Niki S M Schoonenboom; Niels Andreasen; Anders Wallin; John DeBernardis; Daniel Kerkman; Bernhard Heindl; Kaj Blennow; Harald Hampel
Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI.
Neurology 2007;69(24):2205-12.
2007: Anders Wallin; Stefan Ekberg; Karin Lind; V Milos; Ann-Kathrine Granérus; Göran Granerus
Posterior cortical brain dysfunction in cognitively impaired patients with Parkinson's disease--a rCBF scintigraphy study.
Acta neurologica Scandinavica 2007;116(6):347-54.
2007: Ana Verdelho; Sofia Madureira; José M Ferro; Anna Maria Basile; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; Michael Hennerici; John T O'Brien; Leonardo Pantoni; Emilia Salvadori; Philip scheltens; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Domenico Inzitari
Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study.
Journal of neurology, neurosurgery, and psychiatry 2007;78(12):1325-30.
2007: Henrik Zetterberg; Mona Pedersen; Karin Lind; Maria Svensson; Sindre Rolstad; Carl Eckerström; Steinar Syversen; Ulla-Britt Mattsson; Christina Ysander; Niklas Mattsson; Arto Nordlund; hugo vanderstichele; Eugeen Vanmechelen; Michael Jonsson; Ake Edman; Kaj Blennow; Anders Wallin
Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years.
Journal of Alzheimer's disease : JAD 2007;12(3):255-60.
2007: Arto Nordlund; Sindre Rolstad; Ola Klang; Karin Lind; Stefan Hansen; Anders Wallin
Cognitive profiles of mild cognitive impairment with and without vascular disease.
Neuropsychology 2007;21(6):706-12.
2007: Andrew Teodorczuk; John T O'Brien; Michael J Firbank; Leonardo Pantoni; Anna Poggesi; Timo Erkinjuntti; Anders Wallin; Lars-Olof Wahlund; Alida A Gouw; Gunhild Waldemar; Reinhold Schmidt; José M Ferro; Hugues Chabriat; H Bäzner; Domenico Inzitari
White matter changes and late-life depressive symptoms: longitudinal study.
The British journal of psychiatry : the journal of mental science 2007;191():212-7.
2007: Henrik Zetterberg; Michael Jonsson; Abdullah Rasulzada; Cornel Popa; Ewa Styrud; Max Albert Hietala; Lars Rosengren; Anders Wallin; Kaj Blennow
No neurochemical evidence for brain injury caused by heading in soccer.
British journal of sports medicine 2007;41(9):574-7.
2007: Malin E Andersson; Annica Sjölander; Niels Andreasen; Lennart Minthon; Oskar Hansson; Nenad Bogdanovic; Christina Jern; Katarina Jood; Anders Wallin; Kaj Blennow; Henrik Zetterberg
Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease.
International journal of molecular medicine 2007;20(2):233-9.
2007: Sara F Hansson; Anja Hviid Simonsen; Henrik Zetterberg; Oluf Andersen; Sara Haghighi; Inger Fagerberg; Ulf Andréasson; Ann Westman-Brinkmalm; Anders Wallin; Ulla Rüetschi; Kaj Blennow
Cystatin C in cerebrospinal fluid and multiple sclerosis.
Annals of neurology 2007;62(2):193-6; discussion 205.
2007: Zhenyu Zhong; Michael Ewers; Stefan J Teipel; Katharina Bürger; Anders Wallin; Kaj Blennow; Ping He; Carrie McAllister; Harald Hampel; Yong Shen
Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment.
Archives of general psychiatry 2007;64(6):718-26.
2007: Henrik Zetterberg; Max Albert Hietala; Anders Wallin; Kaj Blennow
[Guidelines for brain concussion in sports--how are they to be applied in boxing?].
Läkartidningen 2007;104(22):1715; author reply 1715-6.
2007: Domenico Inzitari; Michela Simoni; Giovanni Pracucci; Anna Poggesi; Anna Maria Basile; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; José M Ferro; Michael Hennerici; Peter Langhorne; John T O'Brien; Frederik Barkhof; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Leonardo Pantoni
Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study.
Archives of internal medicine 2007;167(1):81-8.
2007: Karin Lind; Ake Edman; Arto Nordlund; Tommy Olsson; Anders Wallin
Increased saliva cortisol awakening response in patients with mild cognitive impairment.
Dementia and geriatric cognitive disorders 2007;24(5):389-95.
2007: Asa K Wallin; Niels Andreasen; Sture Eriksson; Stellan Båtsman; Birgitta Nasman; Anne Ekdahl; Lena Kilander; Mikaela Grut; Marie Rydén; Anders Wallin; Mikael Jonsson; Hasse Olofsson; Elisabet Londos; Carina Wattmo; Maria Eriksdotter Jonhagen; Lennart Minthon
Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting.
Dementia and geriatric cognitive disorders 2007;23(3):150-60.
2007: Anja Hviid Simonsen; S F Hansson; U Ruetschi; James McGuire; Vladimir N Podust; Huw A Davies; P Mehta; Gunhild Waldemar; Henrik Zetterberg; Niels Andreasen; Anders Wallin; Kaj Blennow
Amyloid beta1-40 quantification in CSF: comparison between chromatographic and immunochemical methods.
Dementia and geriatric cognitive disorders 2007;23(4):246-50.
2006: Erik Portelius; Henrik Zetterberg; Ulf Andreasson; Gunnar Brinkmalm; Niels Andreasen; Anders Wallin; Ann Westman-Brinkmalm; Kaj Blennow
An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid.
Neuroscience letters 2006;409(3):215-9.
2006: John T O'Brien; Michael J Firbank; Mani S Krishnan; E C W van Straaten; Wiesje M van der Flier; Katja Petrovic; Leonardo Pantoni; Michela Simoni; Timo Erkinjuntti; Anders Wallin; Lars-Olof Wahlund; Domenico Inzitari
White matter hyperintensities rather than lacunar infarcts are associated with depressive symptoms in older people: the LADIS study.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2006;14(10):834-41.
2006: Mani S Krishnan; John T O'Brien; Michael J Firbank; Leonardo Pantoni; Giovanna Carlucci; Timo Erkinjuntti; Anders Wallin; Lars-Olof Wahlund; Philip scheltens; E C W van Straaten; Domenico Inzitari
Relationship between periventricular and deep white matter lesions and depressive symptoms in older people. The LADIS Study.
International journal of geriatric psychiatry 2006;21(10):983-9.
2006: V Stenset; L Johnsen; D Kocot; A Negaard; A Skinningsrud; P Gulbrandsen; Anders Wallin; T Fladby
Associations between white matter lesions, cerebrovascular risk factors, and low CSF Abeta42.
Neurology 2006;67(5):830-3.
2006: Henrik Zetterberg; Max Albert Hietala; Michael Jonsson; Niels Andreasen; Ewa Styrud; Ingvar Karlsson; Ake Edman; Cornel Popa; Abdullah Rasulzada; Lars-Olof Wahlund; Pankaj D Mehta; Lars Rosengren; Kaj Blennow; Anders Wallin
Neurochemical aftermath of amateur boxing.
Archives of neurology 2006;63(9):1277-80.
2006: vladimir hachinski; costantino iadecola; Ronald C. Petersen; Monique Breteler; David L Nyenhuis; Sandra Black; William Powers; Charles DeCarli; José G Merino; Rajesh N. Kalaria; Harry V Vinters; David M Holtzman; Gary A Rosenberg; Anders Wallin; Martin Dichgans; John R Marler; Gabrielle G Leblanc
National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards.
Stroke; a journal of cerebral circulation 2006;37(9):2220-41.
2006: Leonardo Pantoni; Anna Poggesi; Anna Maria Basile; Giovanni Pracucci; Frederik Barkhof; Hugues Chabriat; Timo Erkinjuntti; José M Ferro; Michael Hennerici; John T O'Brien; Reinhold Schmidt; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Domenico Inzitari
Leukoaraiosis predicts hidden global functioning impairment in nondisabled older people: the LADIS (Leukoaraiosis and Disability in the Elderly) Study.
Journal of the American Geriatrics Society 2006;54(7):1095-101.
2006: Karin Lind; Michael Jonsson; Ingvar Karlsson; Magnus Sjögren; Anders Wallin; Ake Edman
Depressive symptoms and white matter changes in patients with dementia.
International journal of geriatric psychiatry 2006;21(2):119-25.
2006: Sofia Madureira; Ana Verdelho; Jose Ferro; Anna Maria Basile; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; Michael Hennerici; John T O'Brien; Leonardo Pantoni; Emilia Salvadori; Philip scheltens; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Domenico Inzitari
Development of a neuropsychological battery for the Leukoaraiosis and Disability in the Elderly Study (LADIS): experience and baseline data.
Neuroepidemiology 2006;27(2):101-16.
2006: Kina Höglund; Anders Wallin; Kaj Blennow
Effect of statins on beta-amyloid metabolism in humans: potential importance for the development of senile plaques in Alzheimer's disease.
Acta neurologica Scandinavica. Supplementum 2006;185():87-92.
2006: Anna Maria Basile; Leonardo Pantoni; Giovanni Pracucci; Kjell Asplund; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; José M Ferro; Michael Hennerici; John T O'Brien; Philip scheltens; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Domenico Inzitari
Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes. The LADIS (Leukoaraiosis and Disability in the Elderly) Study.
Cerebrovascular diseases (Basel, Switzerland) 2006;21(5-6):315-22.
2006: Anders Wallin; Kaj Blennow; Niels Andreasen; Lennart Minthon
CSF biomarkers for Alzheimer's Disease: levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival.
Dementia and geriatric cognitive disorders 2006;21(3):131-8.
2005: Bruce J Brew; Louise Pemberton; Kaj Blennow; Anders Wallin; L Hagberg
CSF amyloid beta42 and tau levels correlate with AIDS dementia complex.
Neurology 2005;65(9):1490-2.
2005: Arto Nordlund; Sindre Rolstad; Per Hellström; Magnus Sjögren; Stefan Hansen; Anders Wallin
The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition.
Journal of neurology, neurosurgery, and psychiatry 2005;76(11):1485-90.
2005: Kaj Blennow; Cornel Popa; Abdullah Rasulzada; Lennart Minthon; Anders Wallin; Henrik Zetterberg
[There is a strong evidence that professional boxing results in chronic brain damage. The more head punches during a boxer's career, the bigger is the risk].
Läkartidningen 2005;102(36):2468-70, 2472-5.
2005: hugo vanderstichele; Geert De Meyer; Niels Andreasen; Vesna Kostanjevecki; Anders Wallin; Annika Olsson; Kaj Blennow; Eugeen Vanmechelen
Amino-truncated beta-amyloid42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairment.
Clinical chemistry 2005;51(9):1650-60.
2005: Michael J Firbank; John T O'Brien; Sanjeet Pakrasi; Leonardo Pantoni; Michela Simoni; Timo Erkinjuntti; Anders Wallin; Lars-Olof Wahlund; Ilse van Straaten; Domenico Inzitari
White matter hyperintensities and depression--preliminary results from the LADIS study.
International journal of geriatric psychiatry 2005;20(7):674-9.
2005: Kina Höglund; Steinar Syversen; Piotr Lewczuk; Anders Wallin; Jens Wiltfang; Kaj Blennow
Statin treatment and a disease-specific pattern of beta-amyloid peptides in Alzheimer's disease.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 2005;164(2):205-14.
2005: Annika Olsson; hugo vanderstichele; Niels Andreasen; Geert De Meyer; Anders Wallin; Björn Holmberg; Lars Rosengren; Eugeen Vanmechelen; Kaj Blennow
Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology.
Clinical chemistry 2005;51(2):336-45.
2005: K Hoglund; K M Thelen; Steinar Syversen; M Sjogren; K von Bergmann; Anders Wallin; Eugeen Vanmechelen; hugo vanderstichele; D Lutjohann; Kaj Blennow
The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease.
Dementia and geriatric cognitive disorders 2005;19(5-6):256-65.
2005: Leonardo Pantoni; Anna Maria Basile; Giovanni Pracucci; Kjell Asplund; daryoush heydari; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; José M Ferro; Michael Hennerici; John T O'Brien; Philip scheltens; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Domenico Inzitari
Impact of age-related cerebral white matter changes on the transition to disability -- the LADIS study: rationale, design and methodology.
Neuroepidemiology 2005;24(1-2):51-62.
2004: Gustavo C Román; Perminder Sachdev; Donald Royall; Roger A Bullock; Jean-Marc Orgogozo; Secundino López-Pousa; Raul Arizaga; Anders Wallin
Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia.
Journal of the neurological sciences 2004;226(1-2):81-7.
2004: Reinhold Schmidt; Philip scheltens; Timo Erkinjuntti; L Pantoni; H S Markus; Anders Wallin; Frederik Barkhof; Franz Fazekas
White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease.
Neurology 2004;63(1):139-44.
2004: Gunbrith Peterson; Anders Wallin
[Different opinions when it comes to research ethics issues concerning patients with dementia. A questionnaire study among members of research ethics committees].
Läkartidningen 2004;101(20):1810-2.
2004: Anders Wallin; L Gustafson; M Sjögren; C Wattmo; Lennart Minthon
Five-year outcome of cholinergic treatment of Alzheimer's disease: early response predicts prolonged time until nursing home placement, but does not alter life expectancy.
Dementia and geriatric cognitive disorders 2004;18(2):197-206.
2004: Frans Verhey; Peter Houx; Natascha Van Lang; Felicia Huppert; Gabriela Stoppe; Jos Saerens; Peter Böhm; Luc De Vreese; Arto Nordlund; Peter P DeDeyn; mirco neri; Jordi Peña-Casanova; Anders Wallin; E L E M Bollen; Huub Middelkoop; Marie-Christine Nargeot; Michèle Puel; Ulrich M Fleischmann; Jelle Jolles
Cross-national comparison and validation of the Alzheimer's Disease Assessment Scale: results from the European Harmonization Project for Instruments in Dementia (EURO-HARPID).
International journal of geriatric psychiatry 2004;19(1):41-50.
2003: Frans Verhey; Felicia A Huppert; Edith C C M Korten; Peter Houx; Marjolein E de Vugt; Natasja D J van Lang; Peter P DeDeyn; Jos Saerens; mirco neri; Luc de Vreese; Jordi Peña-Casanova; Peter Böhm; Gabriela Stoppe; Ulrich Fleischmann; Anders Wallin; Per Hellström; Huub Middelkoop; Ward Bollen; Edwin L Klinkenberg; Mayke M A Derix; Jelle Jolles
Cross-national comparisons of the Cambridge Cognitive Examination-revised: the CAMCOG-R: results from the European Harmonization Project for Instruments in Dementia.
Age and ageing 2003;32(5):534-40.
2003: Elisabeth Tarkowski; Ann Marie Liljeroth; Lennart Minthon; Andrej Tarkowski; Anders Wallin; Kaj Blennow
Cerebral pattern of pro- and anti-inflammatory cytokines in dementias.
Brain research bulletin 2003;61(3):255-60.
2003: Gunbrith Peterson; Anders Wallin
Alzheimer disease ethics--informed consent and related issues in clinical trials: results of a survey among the members of the Research Ethics Committees in Sweden.
International psychogeriatrics / IPA 2003;15(2):157-70.
2003: Alexander Kurz; Matthias Riemenschneider; Anders Wallin
Potential biological markers for cerebrovascular disease.
International psychogeriatrics / IPA 2003;15 Suppl 1():89-97.
2003: Anders Wallin; Veronica Milos; Magnus Sjögren; Leonardo Pantoni; Timo Erkinjuntti
Classification and subtypes of vascular dementia.
International psychogeriatrics / IPA 2003;15 Suppl 1():27-37.
2003: Anders Wallin; Magnus Sjögren; Kaj Blennow; Pia Davidsson
Decreased cerebrospinal fluid acetylcholinesterase in patients with subcortical ischemic vascular dementia.
Dementia and geriatric cognitive disorders 2003;16(4):200-7.
2003: Magnus Sjögren; Kina Gustafsson; Steinar Syversen; Annika Olsson; Ake Edman; Pia Davidsson; Anders Wallin; Kaj Blennow
Treatment with simvastatin in patients with Alzheimer's disease lowers both alpha- and beta-cleaved amyloid precursor protein.
Dementia and geriatric cognitive disorders 2003;16(1):25-30.
2003: Ake Edman; Martin Brunovsky; Magnus Sjögren; Anders Wallin; Milos Matousek
Objective measurement of the alertness level in dementia.
Dementia and geriatric cognitive disorders 2003;15(4):212-7.
2002: Gustavo C Román; Timo Erkinjuntti; Anders Wallin; Leonardo Pantoni; Helena C Chui
Subcortical ischaemic vascular dementia.
Lancet neurology 2002;1(7):426-36.
2002: Karin Lind; Ake Edman; Ingvar Karlsson; Magnus Sjögren; Anders Wallin
Relationship between depressive symptomatology and the subcortical brain syndrome in dementia.
International journal of geriatric psychiatry 2002;17(8):774-8.
2002: Randa Racho El-Akouri; Göran Kurlberg; George Dindelegan; Johan Molne; Anders Wallin; Mats Brännström
Heterotopic uterine transplantation by vascular anastomosis in the mouse.
The Journal of endocrinology 2002;174(2):157-66.
2002: Elisabeth Tarkowski; Razao Issa; Magnus Sjögren; Anders Wallin; Kaj Blennow; Andrej Tarkowski; Pat Kumar
Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia.
Neurobiology of aging 2002;23(2):237-43.
2002: Ake Edman; Sture Eriksson; Anders Wallin
[Clinical investigation of cognitive dysfunction by specialists].
Läkartidningen 2002;99(8):782-5.
2002: Magnus Sjögren; Carsten Wikkelsö; Svante Ostling; Anders Wallin; Kaj Blennow
Biological correlates of clinical subgroups of Alzheimer's disease.
Dementia and geriatric cognitive disorders 2002;14(4):191-7.
2002: Aleksander A Mathé; Hans Agren; Anders Wallin; Kaj Blennow
Calcitonin gene-related peptide and calcitonin in the CSF of patients with dementia and depression: possible disease markers.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(1):41-8.
2002: Magnus Sjögren; Pia Davidsson; Anders Wallin; Ann-Kathrine Granérus; Eva Grundström; Håkan Askmark; Eugeen Vanmechelen; Kaj Blennow
Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms.
Dementia and geriatric cognitive disorders 2002;13(2):112-8.
2001: Magnus Sjögren; M Blomberg; Michael Jonsson; Lars-Olof Wahlund; Ake Edman; Karin Lind; Lars Rosengren; Kaj Blennow; Anders Wallin
Neurofilament protein in cerebrospinal fluid: a marker of white matter changes.
Journal of neuroscience research 2001;66(3):510-6.
2001: Björn Regland; W Lehmann; I Abedini; Kaj Blennow; Michael Jonsson; Ingvar Karlsson; Magnus Sjögren; Anders Wallin; M Xilinas; Carl-Gerhard Gottfries
Treatment of Alzheimer's disease with clioquinol.
Dementia and geriatric cognitive disorders 2001;12(6):408-14.
2001: F Amenta; L Parnetti; V Gallai; Anders Wallin
Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropriate approaches?
Mechanisms of ageing and development 2001;122(16):2025-40.
2001: Anders Wallin; Magnus Sjögren
Cerebrospinal fluid cytoskeleton proteins in patients with subcortical white-matter dementia.
Mechanisms of ageing and development 2001;122(16):1937-49.
2001: M Sjögren; Anders Wallin
Pathophysiological aspects of frontotemporal dementia--emphasis on cytoskeleton proteins and autoimmunity.
Mechanisms of ageing and development 2001;122(16):1923-35.
2001: M Sjögren; hugo vanderstichele; Hans Agren; Olof Zachrisson; Mikael Edsbagge; Carsten Wikkelsø; Ingmar Skoog; Anders Wallin; Lars-Olof Wahlund; J Marcusson; Katarina Nägga; Niels Andreasen; P Davidsson; Eugeen Vanmechelen; Kaj Blennow
Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values.
Clinical chemistry 2001;47(10):1776-81.
2001: Michael A Kern; Michael Friese; E Grundstrom; Laura Korhonen; Anders Wallin; Sten-Magnus Aquilonius; Håkan Askmark; P Schirmacher; Dan Lindholm
Amyotrophic lateral sclerosis: evidence for intact hepatocyte growth factor/met signalling axis.
Cytokine 2001;15(6):315-9.
2001: L Berg; Lars Gustafson; G Hansson; Lena Kilander; S Klingén; Jan Marcusson; B Näsman; Ulla Passant; Lars-Olof Wahlund; Anders Wallin
[Harmonization of dementia diagnoses--a necessary quality assurance].
Läkartidningen 2001;98(34):3531-6.
2001: Magnus Sjögren; Pia Davidsson; Johan Gottfries; hugo vanderstichele; Ake Edman; Eugeen Vanmechelen; Anders Wallin; Kaj Blennow
The cerebrospinal fluid levels of tau, growth-associated protein-43 and soluble amyloid precursor protein correlate in Alzheimer's disease, reflecting a common pathophysiological process.
Dementia and geriatric cognitive disorders 2001;12(4):257-64.
2001: E Linnér; V Popovic; Carl-Gerhard Gottfries; Michael Jonsson; Magnus Sjögren; Anders Wallin
The exfoliation syndrome in cognitive impairment of cerebrovascular or Alzheimer's type.
Acta ophthalmologica Scandinavica 2001;79(3):283-5.
2001: Lars-Olof Wahlund; F Barkhof; F Fazekas; L Bronge; M Augustin; M Sjögren; Anders Wallin; H Ader; Didier LEYS; L Pantoni; Florence Pasquier; Timo Erkinjuntti; Philip scheltens
A new rating scale for age-related white matter changes applicable to MRI and CT.
Stroke; a journal of cerebral circulation 2001;32(6):1318-22.
2001: Milos Matousek; Martin Brunovsky; Ake Edman; Anders Wallin
EEG abnormalities in dementia reflect the parietal lobe syndrome.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2001;112(6):1001-5.
2001: Magnus Sjögren; Pia Davidsson; Mats Tullberg; Lennart Minthon; Anders Wallin; Carsten Wikkelso; Ann-Kathrine Granérus; hugo vanderstichele; Eugeen Vanmechelen; Kaj Blennow
Both total and phosphorylated tau are increased in Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 2001;70(5):624-30.
2001: S F Fabre; Charlotte Forsell; Matti Viitanen; M Sjögren; Anders Wallin; Kaj Blennow; M Blomberg; C Andersen; Lars-Olof Wahlund; Lars Lannfelt
Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency, but no tau gene mutations.
Experimental neurology 2001;168(2):413-8.
2001: Elisabeth Tarkowski; Anders Wallin; Björn Regland; Kaj Blennow; Andrej Tarkowski
Local and systemic GM-CSF increase in Alzheimer's disease and vascular dementia.
Acta neurologica Scandinavica 2001;103(3):166-74.
2001: A Edman; M Mahnfeldt; Anders Wallin
Inter-rater reliability of the STEP protocol.
Journal of geriatric psychiatry and neurology 2001;14(3):140-4.
2001: Magnus Sjögren; C Hesse; Hans Basun; G Köl; H Thostrup; Lena Kilander; Jan Marcusson; Ake Edman; Anders Wallin; Ingvar Karlsson; M Troell; G Wachtmaister; A Ekdahl; Hasse Olofsson; A Sandström; Niels Andreasen; Lennart Minthon; Kaj Blennow
Tacrine and rate of progression in Alzheimer's disease--relation to ApoE allele genotype.
Journal of neural transmission (Vienna, Austria : 1996) 2001;108(4):451-8.
2001: B Robertsson; Kaj Blennow; Görel Bråne; Ake Edman; Ingvar Karlsson; Anders Wallin; Carl-Gerhard Gottfries
Hyperactivity in the hypothalamic-pituitary-adrenal axis in demented patients with delirium.
International clinical psychopharmacology 2001;16(1):39-47.
2001: V Chamoun; A Zeman; Kaj Blennow; P Fredman; Anders Wallin; Geoff Keir; Gavin Giovannoni; Edward J Thompson
Haptoglobins as markers of blood-CSF barrier dysfunction: the findings in normal CSF.
Journal of the neurological sciences 2001;182(2):117-21.
2000: hugo vanderstichele; E Van Kerschaver; C Hesse; Pia Davidsson; M A Buyse; Niels Andreasen; L Minthon; Anders Wallin; Kaj Blennow; Eugeen Vanmechelen
Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2000;7(4):245-58.
2000: Elisabeth Tarkowski; A Ringqvist; Kaj Blennow; Anders Wallin; Ake Wennmalm
Intrathecal release of nitric oxide in Alzheimer's disease and vascular dementia.
Dementia and geriatric cognitive disorders 2000;11(6):322-6.
2000: Magnus Sjögren; L Gustafson; Carsten Wikkelsö; Anders Wallin
Frontotemporal dementia can be distinguished from Alzheimer's disease and subcortical white matter dementia by an anterior-to-posterior rCBF-SPET ratio.
Dementia and geriatric cognitive disorders 2000;11(5):275-85.
2000: Magnus Sjögren; Lars Rosengren; Lennart Minthon; Pia Davidsson; Kaj Blennow; Anders Wallin
Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD.
Neurology 2000;54(10):1960-4.
2000: Leonardo Pantoni; R Rossi; Domenico Inzitari; C Bianchi; M Beneke; Timo Erkinjuntti; Anders Wallin
Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial.
Journal of the neurological sciences 2000;175(2):124-34.
2000: Leonardo Pantoni; C Bianchi; M Beneke; Domenico Inzitari; Anders Wallin; Timo Erkinjuntti
The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia.
Journal of the neurological sciences 2000;175(2):116-23.
2000: Domenico Inzitari; Timo Erkinjuntti; Anders Wallin; Teodoro del Ser; M Romanelli; Leonardo Pantoni
Subcortical vascular dementia as a specific target for clinical trials.
Annals of the New York Academy of Sciences 2000;903():510-21.
2000: Timo Erkinjuntti; Domenico Inzitari; Leonardo Pantoni; Anders Wallin; Philip scheltens; kenneth rockwood; David W Desmond
Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials. Is a focus on subcortical vascular dementia a solution?
Annals of the New York Academy of Sciences 2000;903():262-72.
2000: Barbro Fridén; Anders Wallin; Mats Brännström
Phase-dependent influence of nonsteroidogenic cells on steroidogenesis and prostaglandin production by the human corpus luteum.
Fertility and sterility 2000;73(2):359-65.
2000: Kaj Blennow; Lennart Minthon; Anders Wallin
[New discoveries on Alzheimer disease: new biochemical markers can hopefully improve diagnosis].
Läkartidningen 2000;97(1-2):6-10.
2000: Anders Wallin; Magnus Sjögren; Ake Edman; Kaj Blennow; Björn Regland
Symptoms, vascular risk factors and blood-brain barrier function in relation to CT white-matter changes in dementia.
European neurology 2000;44(4):229-35.
2000: M Sjögren; Lennart Minthon; Pia Davidsson; A Clarberg; hugo vanderstichele; Eugeen Vanmechelen; Anders Wallin; Kaj Blennow
CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(5):563-79.
2000: Kaj Blennow; Anne Ricksten; Jonathan A Prince; Anthony J Brookes; T Emahazion; Carina Wasslavik; Nenad Bogdanovic; Niels Andreasen; Stellan Båtsman; Jan Marcusson; Katarina Nägga; Anders Wallin; Björn Regland; Hasse Olofsson; C Hesse; Pia Davidsson; Lennart Minthon; A Jansson; Lars Palmqvist; Lars Rymo
No association between the alpha2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(8-9):1065-79.
2000: Timo Erkinjuntti; Domenico Inzitari; Leonardo Pantoni; Anders Wallin; Philip scheltens; kenneth rockwood; G C Roman; H Chui; David W Desmond
Research criteria for subcortical vascular dementia in clinical trials.
Journal of neural transmission. Supplementum 2000;59():23-30.
1999: R Rossi; Domenico Inzitari; Leonardo Pantoni; T del Ser; Timo Erkinjuntti; Anders Wallin; C Bianchi; J M Badenas; M Beneke
Nimodipine in subcortical vascular dementia trial.
Alzheimer disease and associated disorders 1999;13 Suppl 3():S159-65.
1999: Anders Wallin; Kaj Blennow; Lars Rosengren
Cerebrospinal fluid markers of pathogenetic processes in vascular dementia, with special reference to the subcortical subtype.
Alzheimer disease and associated disorders 1999;13 Suppl 3():S102-5.
1999: Domenico Inzitari; Timo Erkinjuntti; Anders Wallin; Teodoro del Ser; Leonardo Pantoni
Is subcortical vascular dementia a clinical entity for clinical drug trials?
Alzheimer disease and associated disorders 1999;13 Suppl 3():S66-8.
1999: kenneth rockwood; J Bowler; Timo Erkinjuntti; vladimir hachinski; Anders Wallin
Subtypes of vascular dementia.
Alzheimer disease and associated disorders 1999;13 Suppl 3():S59-65.
1999: Leonardo Pantoni; D Leys; Franz Fazekas; W T Longstreth; Domenico Inzitari; Anders Wallin; Massimo Filippi; Philip scheltens; Timo Erkinjuntti; vladimir hachinski
Role of white matter lesions in cognitive impairment of vascular origin.
Alzheimer disease and associated disorders 1999;13 Suppl 3():S49-54.
1999: Anders Wallin; C Jennersjö; Ann-Kathrine Granérus
Prevalence of dementia and regional brain syndromes in long-standing Parkinson's disease.
Parkinsonism & related disorders 1999;5(3):103-10.
1999: Barbro Fridén; HG Hagström; Bo Lindblom; Peter Sjöblom; Anders Wallin; Mats Brännström; Mats Hahlin
Cell characteristics and function of two enriched fraction of human luteal cells prolonged culture.
Molecular human reproduction 1999;5(8):714-9.
1999: Elisabeth Tarkowski; Kaj Blennow; Anders Wallin; Andrej Tarkowski
Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia.
Journal of clinical immunology 1999;19(4):223-30.
1999: B Robertsson; L Olsson; Anders Wallin
Occurrence of delirium in different regional brain syndromes.
Dementia and geriatric cognitive disorders 1999;10(4):278-83.
1999: Niels Andreasen; C Hesse; Pia Davidsson; Lennart Minthon; Anders Wallin; Bengt Winblad; hugo vanderstichele; Eugeen Vanmechelen; Kaj Blennow
Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.
Archives of neurology 1999;56(6):673-80.
1999: Lars Rosengren; Jan-Erik Karlsson; Magnus Sjögren; Kaj Blennow; Anders Wallin
Neurofilament protein levels in CSF are increased in dementia.
Neurology 1999;52(5):1090-3.
1998: Magnus Sjögren; L Minthon; U Passant; Kaj Blennow; Anders Wallin
Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease.
Neurobiology of aging 1998;19(5):379-84.
1998: Anders Wallin
The overlap between Alzheimer's disease and vascular dementia: the role of white matter changes.
Dementia and geriatric cognitive disorders 1998;9 Suppl 1():30-5.
1998: Ake Edman; Milos Matousek; Magnus Sjögren; Anders Wallin
Longitudinal EEG findings in dementia related to the parietal brain syndrome and the degree of dementia.
Dementia and geriatric cognitive disorders 1998;9(4):199-204.
1998: Ingmar Skoog; Anders Wallin; Pam Fredman; C Hesse; O Aevarsson; Ingvar Karlsson; Carl-Gerhard Gottfries; Kaj Blennow
A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia.
Neurology 1998;50(4):966-71.
1998: Philip scheltens; T Erkinjunti; Didier LEYS; Lars-Olof Wahlund; Domenico Inzitari; T del Ser; Florence Pasquier; Frederik Barkhof; R Mäntylä; John V Bowler; Anders Wallin; J Ghika; Franz Fazekas; Leonardo Pantoni
White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes.
European neurology 1998;39(2):80-9.
1998: B Robertsson; Kaj Blennow; Carl-Gerhard Gottfries; Anders Wallin
Delirium in dementia.
International journal of geriatric psychiatry 1998;13(1):49-56.
1997: Magnus Sjögren; Anders Wallin; Ake Edman
Symptomatological characteristics distinguish between frontotemporal dementia and vascular dementia with a dominant frontal lobe syndrome.
International journal of geriatric psychiatry 1997;12(6):656-61.
1997: LE Augustinsson; Kaj Blennow; Christian Blomstrand; Görel Bråne; R Ekman; Pam Fredman; Ingvar Karlsson; M Kihlgren; W Lehmann; Annika Lekman; Jan-Eric Månsson; I Ramström; Anders Wallin; Carsten Wikkelsö; Carl-Gerhard Gottfries; Lars Svennerholm
Intracerebroventricular administration of GM1 ganglioside to presenile Alzheimer patients.
Dementia and geriatric cognitive disorders 1997;8(1):26-33.
1996: Ulf Zackrisson; M Mikuni; Anders Wallin; Dick Delbro; Lars Hedin; Mats Brännström
Cell-specific localization of nitric oxide synthases (NOS) in the rat ovary during follicular development, ovulation and luteal formation.
Human reproduction (Oxford, England) 1996;11(12):2667-73.
1996: Anders Wallin; Ake Edman; Kaj Blennow; Carl-Gerhard Gottfries; Ingvar Karlsson; Björn Regland; Magnus Sjögren
Stepwise comparative status analysis (STEP): a tool for identification of regional brain syndromes in dementia.
Journal of geriatric psychiatry and neurology 1996;9(4):185-99.
1996: Mikael Landén; A Thorsell; Anders Wallin; Kaj Blennow
The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 1996;61(4):352-6.
1996: GG Bader; K Turesson; Anders Wallin
Sleep-related breathing and movement disorders in healthy elderly and demented subjects.
Dementia (Basel, Switzerland) 1996;7(5):279-87.
1996: Mikael Landén; C Hesse; Pam Fredman; Björn Regland; Anders Wallin; Kaj Blennow
Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the apoE4 isoform.
Dementia (Basel, Switzerland) 1996;7(5):273-8.
1996: Anders Wallin; Kaj Blennow; Lars Rosengren
Glial fibrillary acidic protein in the cerebrospinal fluid of patients with dementia.
Dementia (Basel, Switzerland) 1996;7(5):267-72.
1996: Anders Wallin
[Tacrine against Alzheimer disease? Still uncertain for which patients may the treatment be beneficial].
Läkartidningen 1996;93(1-2):22-4.
1996: Anders Wallin; Kaj Blennow; A Edman; J E Månsson
Decreased lumbar cerebrospinal fluid levels of monoamine metabolites in vascular dementia.
International psychogeriatrics / IPA 1996;8(3):425-36.
1996: Anders Wallin
Current definition and classification of dementia diseases.
Acta neurologica Scandinavica. Supplementum 1996;168():39-44.
1996: Kaj Blennow; Ingmar Skoog; Anders Wallin; Carsten Wikkelsö; P Fredman
Immunoglobulin M in cerebrospinal fluid: reference values derived from 111 healthy individuals 18-88 years of age.
European neurology 1996;36(4):201-5.
1996: Anders Wallin; Kaj Blennow
Clinical subgroups of the Alzheimer syndrome.
Acta neurologica Scandinavica. Supplementum 1996;165():51-7.
1995: Kaj Blennow; Anders Wallin; Hans Agren; C Spenger; J Siegfried; Eugeen Vanmechelen
Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?
Molecular and chemical neuropathology / sponsored by the International Society for Neurochemistry and the World Federation of Neurology and research groups on neurochemistry and cerebrospinal fluid 1995;26(3):231-45.
1995: Jan-Olof Karlsson; Kaj Blennow; I Janson; Klas Blomgren; Ingvar Karlsson; Björn Regland; Anders Wallin; Carl-Gerhard Gottfries
Increased proteolytic activity in lymphocytes from patients with early onset Alzheimer's disease.
Neurobiology of aging 1995;16(6):901-6.
1995: Ake Edman; M Matousek; Anders Wallin
EEG findings in dementia are related to the parietal lobe syndrome.
Dementia (Basel, Switzerland) 1995;6(6):323-9.
1995: Kaj Blennow; Pia Davidsson; Anders Wallin; R Ekman
Chromogranin A in cerebrospinal fluid: a biochemical marker for synaptic degeneration in Alzheimer's disease?
Dementia (Basel, Switzerland) 1995;6(6):306-11.
1995: Anders Wallin
[Subtype identification in vascular dementia. An important step towards more precise diagnosis and improved treatment].
Läkartidningen 1995;92(36):3217-9.
1995: Markus Heilig; Magnus Sjögren; Kaj Blennow; R Ekman; Anders Wallin
Cerebrospinal fluid neuropeptides in Alzheimer's disease and vascular dementia.
Biological psychiatry 1995;38(4):210-6.
1995: Kaj Blennow; Anders Wallin; J K Chong
Cerebrospinal fluid 'neuronal thread protein' comes from serum by passage over the blood-brain barrier.
Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration 1995;4(2):187-93.
1995: Johan Gottfries; Kaj Blennow; Anders Wallin; Carl-Gerhard Gottfries
Diagnosis of dementias using partial least squares discriminant analysis.
Dementia (Basel, Switzerland) 1995;6(2):83-8.
1994: Carl-Gerhard Gottfries; Jan Balldin; Kaj Blennow; G Bråne; Ingvar Karlsson; Björn Regland; Anders Wallin
Regulation of the hypothalamic-pituitary-adrenal axis in dementia disorders.
Annals of the New York Academy of Sciences 1994;746():336-43; discussion 343-4.
1994: Jan Balldin; Kaj Blennow; G Bråne; Carl-Gerhard Gottfries; Ingvar Karlsson; Björn Regland; Anders Wallin
Relationship between mental impairment and HPA axis activity in dementia disorders.
Dementia (Basel, Switzerland) 1994;5(5):252-6.
1994: J Thorpe; L P Widman; Anders Wallin; J Beiswanger; H T Blumenthal
Comorbidity of other chronic age-dependent diseases in dementia.
Aging (Milan, Italy) 1994;6(3):159-66.
1994: Anders Wallin; Kaj Blennow
The clinical diagnosis of vascular dementia.
Dementia (Basel, Switzerland) 1994;5(3-4):181-4.
1994: Carl-Gerhard Gottfries; Kaj Blennow; Ingvar Karlsson; Anders Wallin
The neurochemistry of vascular dementia.
Dementia (Basel, Switzerland) 1994;5(3-4):163-7.
1994: K M Mattila; Tuula Pirttilä; Kaj Blennow; Anders Wallin; Matti Viitanen; H Frey
Altered blood-brain-barrier function in Alzheimer's disease?
Acta neurologica Scandinavica 1994;89(3):192-8.
1994: Kaj Blennow; P Fredman; Anders Wallin; Carl-Gerhard Gottfries; H Frey; T Pirttilä; Ingmar Skoog; Carsten Wikkelsö; L Svennerholm
Formulas for the quantitation of intrathecal IgG production. Their validity in the presence of blood-brain barrier damage and their utility in multiple sclerosis.
Journal of the neurological sciences 1994;121(1):90-6.
1994: Kaj Blennow; Pia Davidsson; Anders Wallin; Carl-Gerhard Gottfries; Lars Svennerholm
Ubiquitin in cerebrospinal fluid in Alzheimer's disease and vascular dementia.
International psychogeriatrics / IPA 1994;6(1):13-22; discussion 59-60.
1994: Carl-Gerhard Gottfries; Jan Balldin; Kaj Blennow; G Bråne; Ingvar Karlsson; Björn Regland; Anders Wallin
Hypothalamic dysfunction in dementia.
Journal of neural transmission. Supplementum 1994;43():203-9.
1994: Kaj Blennow; Anders Wallin; R Ekman
Neuron specific enolase in cerebrospinal fluid: a biochemical marker for neuronal degeneration in dementia disorders?
Journal of neural transmission. Parkinson's disease and dementia section 1994;8(3):183-91.
1993: Kaj Blennow; Anders Wallin; O Häger
Low frequency of post-lumbar puncture headache in demented patients.
Acta neurologica Scandinavica 1993;88(3):221-3.
1993: Anders Wallin; Kaj Blennow
Heterogeneity of vascular dementia: mechanisms and subgroups.
Journal of geriatric psychiatry and neurology 1993;6(3):177-88.
1993: Anders Wallin
[Alzheimer's disease. Computer tomography--a good diagnostic method?].
Läkartidningen 1993;90(21):2029-30.
1993: Kerstin Landin; Kaj Blennow; Anders Wallin; Carl-Gerhard Gottfries
Low blood pressure and blood glucose levels in Alzheimer's disease. Evidence for a hypometabolic disorder?
Journal of internal medicine 1993;233(4):357-63.
1993: Anders Wallin; Kaj Blennow
[The concept of dementia--does it enlighten or confuse?].
Läkartidningen 1993;90(13):1235-6.
1993: Anders Wallin
[Brain clinics are needed].
Läkartidningen 1993;90(11):1029-30.
1993: Kaj Blennow; Anders Wallin; Carl-Gerhard Gottfries; Ingvar Karlsson; J E Månsson; Ingmar Skoog; Carsten Wikkelsö; Lars Svennerholm
Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18-88 years of age.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1993;3(1):55-61.
1993: Kaj Blennow; P Fredman; Anders Wallin; Carl-Gerhard Gottfries; Ingmar Skoog; Carsten Wikkelsö; Lars Svennerholm
Protein analysis in cerebrospinal fluid. III. Relation to blood-cerebrospinal fluid barrier function for formulas for quantitative determination of intrathecal IgG production.
European neurology 1993;33(2):134-42.
1993: Kaj Blennow; P Fredman; Anders Wallin; Carl-Gerhard Gottfries; Ingvar Karlsson; G Långström; Ingmar Skoog; Lars Svennerholm; Carsten Wikkelsö
Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age.
European neurology 1993;33(2):129-33.
1993: Kaj Blennow; P Fredman; Anders Wallin; Carl-Gerhard Gottfries; G Långström; Lars Svennerholm
Protein analyses in cerebrospinal fluid. I. Influence of concentration gradients for proteins on cerebrospinal fluid/serum albumin ratio.
European neurology 1993;33(2):126-8.
1993: Kaj Blennow; Anders Wallin; Carl-Gerhard Gottfries; J E Månsson; Lars Svennerholm
Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid.
Journal of neural transmission. Parkinson's disease and dementia section 1993;5(1):5-15.
1992: Kaj Blennow; Pia Davidsson; Anders Wallin; Pam Fredman; Carl-Gerhard Gottfries; Jan-Eric Månsson; Lars Svennerholm
Differences in cerebrospinal fluid gangliosides between "probable Alzheimer's disease" and normal aging.
Aging (Milan, Italy) 1992;4(4):301-6.
1992: Kaj Blennow; Anders Wallin
Clinical heterogeneity of probable Alzheimer's disease.
Journal of geriatric psychiatry and neurology 1992;5(2):106-13.
1992: Björn Regland; L Abrahamsson; Kaj Blennow; Carl-Gerhard Gottfries; Anders Wallin
Vitamin B12 in CSF: reduced CSF/serum B12 ratio in demented men.
Acta neurologica Scandinavica 1992;85(4):276-81.
1992: Pam Fredman; Anders Wallin; Kaj Blennow; Pia Davidsson; Carl-Gerhard Gottfries; Lars Svennerholm
Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia.
Acta neurologica Scandinavica 1992;85(2):103-6.
1992: Anders Wallin; Kaj Blennow
Clinical diagnosis of Alzheimer's disease by primary care physicians and specialists.
Acta neurologica Scandinavica. Supplementum 1992;139():26-31.
1992: Kaj Blennow; Anders Wallin; Carl-Gerhard Gottfries; Annika Lekman; Ingvar Karlsson; Ingmar Skoog; Lars Svennerholm
Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease.
Neurobiology of aging 1992;13(1):107-13.
1991: Kaj Blennow; Pia Davidsson; Anders Wallin; Pam Fredman; Carl-Gerhard Gottfries; Ingvar Karlsson; Jan-Eric Månsson; Lars Svennerholm
Gangliosides in cerebrospinal fluid in 'probable Alzheimer's disease'.
Archives of neurology 1991;48(10):1032-5.
1991: Anders Wallin; Arvid Carlsson; R Ekman; Carl-Gerhard Gottfries; Ingvar Karlsson; Lars Svennerholm; E Widerlöv
Hypothalamic monoamines and neuropeptides in dementia.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1991;1(2):165-8.
1991: Kaj Blennow; Anders Wallin; C Uhlemann; Carl-Gerhard Gottfries
White-matter lesions on CT in Alzheimer patients: relation to clinical symptomatology and vascular factors.
Acta neurologica Scandinavica 1991;83(3):187-93.
1991: Anders Wallin; Kaj Blennow
Pathogenetic basis of vascular dementia.
Alzheimer disease and associated disorders 1991;5(2):91-102.
1990: Anders Wallin
[A consensus on dementia (II): A survey and special diagnosis].
Läkartidningen 1990;87(51-52):4443-8.
1990: Kaj Blennow; Anders Wallin; Carl-Gerhard Gottfries
Confusional symptomatology distinguishes early- and late-onset Alzheimer's disease.
Aging (Milan, Italy) 1990;2(4):395-401.
1990: R Adolfsson; L Gustafson; Ingmar Skoog; Matti Viitanen; Anders Wallin
[A check list for diagnosis and basic investigation of dementia in primary health care].
Läkartidningen 1990;87(48):4098-9.
1990: Anders Wallin
[A consensus on dementia diseases (I): Classification and investigation].
Läkartidningen 1990;87(46):3856-65.
1990: Kaj Blennow; Anders Wallin; P Fredman; Carl-Gerhard Gottfries; Ingvar Karlsson; Lars Svennerholm
Intrathecal synthesis of immunoglobulins in patients with Alzheimer's disease.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1990;1(1):79-81.
1990: E Nilsson; Irina Alafuzoff; Kaj Blennow; Klas Blomgren; C M Hall; I Janson; Ingvar Karlsson; Anders Wallin; Carl-Gerhard Gottfries; Jan-Olof Karlsson
Calpain and calpastatin in normal and Alzheimer-degenerated human brain tissue.
Neurobiology of aging 1990;11(4):425-31.
1990: Kaj Blennow; Anders Wallin; Pam Fredman; Ingvar Karlsson; Carl-Gerhard Gottfries; Lars Svennerholm
Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors.
Acta neurologica Scandinavica 1990;81(4):323-6.
1990: Anders Wallin; Kaj Blennow; Pam Fredman; Carl-Gerhard Gottfries; Ingvar Karlsson; Lars Svennerholm
Blood brain barrier function in vascular dementia.
Acta neurologica Scandinavica 1990;81(4):318-22.
1990: E Mohr; C Carter; Anders Wallin
Neurochemical substrates of human aging and dementia.
Pharmacopsychiatry 1990;23 Suppl 2():53-5.
1990: Anders Wallin; Kaj Blennow; Pam Fredman; Carl-Gerhard Gottfries; Ingvar Karlsson; Lars Svennerholm
Intrathecal synthesis of immunoglobulin G in vascular dementia.
Acta neurologica Scandinavica 1990;81(2):168-72.
1990: Anders Wallin; Carl-Gerhard Gottfries
Biochemical substrates in normal aging and Alzheimer's disease.
Pharmacopsychiatry 1990;23 Suppl 2():37-43.
1990: Kaj Blennow; Anders Wallin; Pia Davidsson; P Fredman; Carl-Gerhard Gottfries; Lars Svennerholm
Intra-blood-brain-barrier synthesis of immunoglobulins in patients with dementia of the Alzheimer type.
Alzheimer disease and associated disorders 1990;4(2):79-86.
1990: Lars Svennerholm; Carl-Gerhard Gottfries; Kaj Blennow; Pam Fredman; Ingvar Karlsson; Jan-Eric Månsson; G Toffano; Anders Wallin
Parenteral administration of GM1 ganglioside to presenile Alzheimer patients.
Acta neurologica Scandinavica 1990;81(1):48-53.
1989: Anders Wallin; Kaj Blennow; C Uhlemann; G Långström; Carl-Gerhard Gottfries
White matter low attenuation on computed tomography in Alzheimer's disease and vascular dementia--diagnostic and pathogenetic aspects.
Acta neurologica Scandinavica 1989;80(6):518-23.
1989: Anders Wallin; Carl-Gerhard Gottfries; Ingvar Karlsson; Lars Svennerholm
Decreased myelin lipids in Alzheimer's disease and vascular dementia.
Acta neurologica Scandinavica 1989;80(4):319-23.
1989: Anders Wallin; Irina Alafuzoff; Arvid Carlsson; S A Eckernäs; Carl-Gerhard Gottfries; Ingvar Karlsson; Lars Svennerholm; Bengt Winblad
Neurotransmitter deficits in a non-multi-infarct category of vascular dementia.
Acta neurologica Scandinavica 1989;79(5):397-406.
1989: G Bråne; Carl-Gerhard Gottfries; Kaj Blennow; Ingvar Karlsson; Annika Lekman; L Parnetti; Lars Svennerholm; Anders Wallin
Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia.
Alzheimer disease and associated disorders 1989;3(3):148-56.
1988: E Danielsson; S A Eckernäs; A Westlind-Danielsson; O Nordström; Tamas Bartfai; Carl-Gerhard Gottfries; Anders Wallin
VIP-sensitive adenylate cyclase, guanylate cyclase, muscarinic receptors, choline acetyltransferase and acetylcholinesterase, in brain tissue afflicted by Alzheimer's disease/senile dementia of the Alzheimer type.
Neurobiology of aging 1988;9(2):153-62.
1987: A McRae-Degueurce; S Booj; Kenneth G Haglid; L Rosengren; Jan-Erik Karlsson; I Karlsson; Anders Wallin; L Svennerholm; Carl-Gerhard Gottfries; A Dahlstrom
Antibodies in cerebrospinal fluid of some Alzheimer disease patients recognize cholinergic neurons in the rat central nervous system.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(24):9214-8.
1987: K Andersen; Jan Balldin; Carl-Gerhard Gottfries; Ann-Kathrine Granérus; K Modigh; L Svennerholm; Anders Wallin
A double-blind evaluation of electroconvulsive therapy in Parkinson's disease with "on-off" phenomena.
Acta neurologica Scandinavica 1987;76(3):191-9.